George M. Haig

1.6k total citations
31 papers, 1.2k citations indexed

About

George M. Haig is a scholar working on Psychiatry and Mental health, Molecular Biology and Pharmacology. According to data from OpenAlex, George M. Haig has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in George M. Haig's work include Receptor Mechanisms and Signaling (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Mast cells and histamine (4 papers). George M. Haig is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Mast cells and histamine (4 papers). George M. Haig collaborates with scholars based in United States, Egypt and Switzerland. George M. Haig's co-authors include James P. Young, Susan Martin, Uma Sharma, Ahmed A. Othman, Susan Lee Simpson, Jeannette A. Barrett, W. Rachel Duan, Leslie J. Crofford, Howard N. Bockbrader and Lesley M. Arnold and has published in prestigious journals such as American Journal of Psychiatry, Journal of Bone and Joint Surgery and Pain.

In The Last Decade

George M. Haig

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George M. Haig United States	16	571	448	241	179	172	31	1.2k
Linda A. Hershey United States	24	540 0.9×	180 0.4×	159 0.7×	277 1.5×	196 1.1×	76	2.0k
Catherine Buettner United States	23	623 1.1×	106 0.2×	176 0.7×	204 1.1×	257 1.5×	36	1.7k
Danuta Ryglewicz Poland	27	196 0.3×	92 0.2×	102 0.4×	317 1.8×	165 1.0×	118	1.7k
Chieh‐Liang Huang Taiwan	15	351 0.6×	94 0.2×	85 0.4×	168 0.9×	216 1.3×	36	1.2k
Abdullah Al‐Asmi Oman	19	329 0.6×	74 0.2×	275 1.1×	115 0.6×	96 0.6×	94	1.3k
Roger Desnyder Belgium	15	459 0.8×	203 0.5×	32 0.1×	257 1.4×	241 1.4×	17	2.0k
Daniel K. Kajdasz United States	24	821 1.4×	1.1k 2.4×	321 1.3×	426 2.4×	78 0.5×	41	1.9k
Jens Bohlken Germany	19	441 0.8×	132 0.3×	47 0.2×	230 1.3×	232 1.3×	106	1.5k
M. Pappagallo United States	25	163 0.3×	689 1.5×	259 1.1×	1.2k 6.6×	203 1.2×	81	2.4k
AF Cohen Netherlands	17	253 0.4×	294 0.7×	258 1.1×	60 0.3×	170 1.0×	31	1.0k

Countries citing papers authored by George M. Haig

Since Specialization

Citations

This map shows the geographic impact of George M. Haig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George M. Haig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George M. Haig more than expected).

Fields of papers citing papers by George M. Haig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George M. Haig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George M. Haig. The network helps show where George M. Haig may publish in the future.

Co-authorship network of co-authors of George M. Haig

This figure shows the co-authorship network connecting the top 25 collaborators of George M. Haig. A scholar is included among the top collaborators of George M. Haig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George M. Haig. George M. Haig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haig, George M., Deli Wang, Jun Zhao, Mohamed I. A. Othman, & Earle Bain. (2017). Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia. The Journal of Clinical Psychiatry. 79(3). 13 indexed citations

Hudzik, Thomas J., Ana M. Basso, James J. Lynch, et al.. (2017). Preclinical abuse liability assessment of ABT-126, an agonist at the α7 nicotinic acetylcholine receptor (nAChR). Pharmacology Biochemistry and Behavior. 158. 22–31. 2 indexed citations

Georgiades, Anastasia, Vicki G. Davis, Alexandra S. Atkins, et al.. (2017). Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients. Schizophrenia Research. 190. 172–179. 37 indexed citations

Haig, George M., Earle Bain, Weining Robieson, Jeffrey D. Baker, & Ahmed A. Othman. (2016). A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia. American Journal of Psychiatry. 173(8). 827–835. 49 indexed citations

Haig, George M., Deli Wang, Ahmed A. Othman, & Jun Zhao. (2016). The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study. Neuropsychopharmacology. 41(12). 2893–2902. 30 indexed citations

Hufford, Michael R., Vicki G. Davis, Dana Hilt, et al.. (2014). Circadian rhythms in cognitive functioning among patients with schizophrenia: Impact on signal detection in clinical trials of potential pro-cognitive therapies. Schizophrenia Research. 159(1). 205–210. 13 indexed citations

Haig, George M., Earle Bain, Weining Robieson, et al.. (2014). A Randomized Trial of the Efficacy and Safety of the H3 Antagonist ABT-288 in Cognitive Impairment Associated With Schizophrenia. Schizophrenia Bulletin. 40(6). 1433–1442. 50 indexed citations

Othman, Ahmed A., George M. Haig, Hana Florian, et al.. (2012). Safety, tolerability and pharmacokinetics of the histamine H₃ receptor antagonist, ABT‐288, in healthy young adults and elderly volunteers. British Journal of Clinical Pharmacology. 75(5). 1299–1311. 14 indexed citations

Bockbrader, Howard N., Louis L. Radulovic, Edward L. Posvar, et al.. (2010). Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers. The Journal of Clinical Pharmacology. 50(8). 941–950. 144 indexed citations

10.

Chapel, Sunny, Matt Hutmacher, George M. Haig, et al.. (2009). Exposure‐Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation. The Journal of Clinical Pharmacology. 49(11). 1297–1308. 47 indexed citations

11.

Crofford, Leslie J., Philip J. Mease, Susan Lee Simpson, et al.. (2008). Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 136(3). 419–431. 180 indexed citations

12.

Arnold, Lesley M., I. Jon Russell, Erdal Diri, et al.. (2008). A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia. Journal of Pain. 9(9). 792–805. 233 indexed citations

13.

Arnold, Lesley M., W. Rachel Duan, Erdal Diri, et al.. (2007). (695). Journal of Pain. 8(4). S24–S24. 6 indexed citations

14.

Wit, Harriet de, et al.. (2006). Evaluation of the Abuse Potential of Pagoclone, a Partial GABAA Agonist. Journal of Clinical Psychopharmacology. 26(3). 268–273. 6 indexed citations

15.

Ouellet, Danièle, Suzie A. Ferreira, Scott Fountain, et al.. (2003). Pharmacokinetic Interaction of Gabapentin and Naproxen in Rats and Humans. Clinical Pharmacology & Therapeutics. 73(2). 7 indexed citations

16.

Haig, George M., Howard N. Bockbrader, David Wesche, et al.. (2001). Single‐Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children. The Journal of Clinical Pharmacology. 41(5). 507–514. 58 indexed citations

17.

Murkin, John M., George M. Haig, Nicholas Cicutti, et al.. (2000). Aprotinin Decreases Exposure to Allogeneic Blood During Primary Unilateral Total Hip Replacement*. Journal of Bone and Joint Surgery. 82(5). 675–684. 64 indexed citations

18.

Pryka, Randy D. & George M. Haig. (1994). Meropenem: A New Carbapenem Antimicrobial. Annals of Pharmacotherapy. 28(9). 1045–1054. 25 indexed citations

19.

Haig, George M., et al.. (1991). Effect of pharmacist participation on a medical team on costs, charges, and length of stay. American Journal of Health-System Pharmacy. 48(7). 1457–1462. 48 indexed citations

20.

Haig, George M.. (1986). Portable thermogram technique for topically applied benzydamine cream in acute soft-tissue injuries.. PubMed. 8(2). 145–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact